[Intraperitoneal chemotherapy in ovarian carcinoma. Life prolonging in selected patients].
Ottevanger
P B
PB
Afd. Medische Oncologie, Universitair Medisch Centrum St Radboud, Nijmegen. p.ottevanger@onco.umcn.nl
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects / Q000379:methods*; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy* / Q000401:mortality; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis; D013997:Time Factors
D000970:Antineoplastic Agents